Global Synthetic Cannabinoids Market Size Revenue Forecasted to Surpass $12.4 Billion by 2030, At a CAGR of 21.81%
August 21, 2023 07:20 ET
|
Zion Market Research
New York, NY, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Synthetic Cannabinoids Market By Indication (Nausea/Vomiting, Pain Management, And...
NOTICE TO DISREGARD -- Avicanna Inc.
March 15, 2021 18:40 ET
|
Avicanna Inc.
TORONTO, March 15, 2021 (GLOBE NEWSWIRE) -- We are advised by Avicanna Inc. that journalists and other readers should disregard the news release, “Avicanna to present at the Q1 Virtual Investor...
UPDATE: ECOFIBRE LIMITED – Ananda Health products used in first clinical trial on hemp-derived CBD to treat chemotherapy-induced peripheral neuropathy
July 23, 2020 08:00 ET
|
Ecofibre
Georgetown, Kentucky, July 23, 2020 (GLOBE NEWSWIRE) -- Ecofibre Limited (Ecofibre, Company) (ASX:EOF, OTC-NASDAQ Intl Designation: EOFBF) is pleased to announce that the Lankenau Institute for...
ECOFIBRE LIMITED – Ananda Health products used in first FDA authorized clinical trial on hemp-derived CBD to treat chemotherapy induced peripheral neuropathy
July 07, 2020 08:58 ET
|
Ecofibre
Georgetown, Kentucky, July 07, 2020 (GLOBE NEWSWIRE) -- Ecofibre Limited (Ecofibre, Company) (ASX:EOF, OTC-NASDAQ Intl Designation: EOFBF) is pleased to announce that the Lankenau Institute for...